News Releases – News & Events | Oncolytics Biotech Inc.

News Releases

Latest News Release

Dec 2, 2011

Oncolytics Biotech^® Inc. Announces Phase 2 Clinical Trial of REOLYSIN^® in Combination with Gemcitabine in Pancreatic Cancer Reaches Primary Endpoint

Nov 21, 2011

Oncolytics Biotech^® Inc. Announces Start of Conformity Testing with SAFC®

Nov 14, 2011

Oncolytics Biotech^® Inc. Announces Positive Results of U.S. Phase 2 Clinical Trial Investigating REOLYSIN^® in Combination with Paclitaxel and Carboplatin in Head and Neck Cancers

Nov 14, 2011

Oncolytics Biotech^® Inc. Collaborators to Present Positive Phase 2 REOLYSIN Clinical Data in Pancreatic Cancer at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

Nov 11, 2011

Oncolytics Biotech^® Inc. to Host Conference Call to Discuss Clinical Data Being Presented at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

Nov 10, 2011

Oncolytics Biotech^® Inc. Announces Third Quarter 2011 Results

Nov 10, 2011

Oncolytics Biotech Announces Appointments to Senior Management Team

Sep 22, 2011

Media Advisory – Oncolytics Biotech^® Inc. to Present at the JMP Securities Healthcare Conference

1
2
3
4
5